Impact of CYP2C19 variants on drug efficacy of clopidogrel and 1-year clinical outcomes in coronary heart patients undergoing PCI

被引：0
|
作者：
Hong, Sun [1 ]
Sun, Hong [1 ]
Chen, Hui [2 ]
机构：
[1] Fujian Med Univ, Fujian Prov Hosp, Dept Pharm, Prov Clin Coll, Fuzhou, Peoples R China
[2] Fujian Med Univ, Fujian Prov Cardiovasc Dis Inst, Prov Clin Coll, Hypertens Lab, Fuzhou, Fujian Province, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2016.07.389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW27-e0434
引用
收藏
页码：C104 / C104
页数：1
相关论文
共 50 条
  • [1] IMPACT OF CYP2C19 VARIANTS ON DRUG EFFICACY OF CLOPIDOGREL AND 1-YEAR CLINICAL OUTCOMES IN CORONARY HEART PATIENTS UNDERGOING PCI
    Sun, Hong
    Wei, Xiao-xia
    Chen, Hui
    JOURNAL OF HYPERTENSION, 2016, 34 : E155 - E156
  • [2] Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention
    Sun, Hong
    Qu, Qiang
    Chen, Zhen-Fan
    Tan, Sheng-Lan
    Zhou, Hai-Jun
    Qu, Jian
    Chen, Hui
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [3] Impact of CYP2C19 variants on clinical efficacy of doubled maintenance dose of clopidogrel in coronary artery disease Syrian patients undergoing percutaneous coronary intervention
    Saleh, Nour Haj
    Youssef, Lama
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1710 - 1710
  • [4] The Impact of CYP2C19 Polymorphisms on Clinical Outcomes of the Patients Treated with Clopidogrel
    Lee, Y.
    Kim, M.
    Kim, H.
    Lee, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 760 - 760
  • [5] Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes
    Chen, Keguang
    Zhang, Rui
    Liu, Huanjun
    Guo, Xi
    Li, Pingli
    Liu, Xuehong
    CLINICAL LABORATORY, 2016, 62 (09) : 1773 - 1780
  • [6] Correlation between CYP2C19 gene polymorphism and clinical efficacy of clopidogrel in patients with coronary artery heart disease
    Sun, Kui
    Zhang, Pei-Pei
    Gong, Ya-Nan
    Wang, Xiang-Bo
    Meng, Yan
    Zhang, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (07): : 5290 - 5296
  • [7] Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention
    Park, Mahn-Won
    Her, Sung Ho
    Kim, Ho-Sook
    Choi, Yun-Seok
    Park, Chul-Soo
    Koh, Yoon-Seok
    Park, Hun-Jun
    Kim, Pum-Joon
    Kim, Chan Joon
    Jeon, Doo Soo
    Shin, Dong Il
    Seo, Suk Min
    Yoo, Ki-Dong
    Kim, Dong Bin
    Kim, Hee Yeol
    Lee, Jong Min
    Chung, Wook-Sung
    Seung, Ki-Bae
    Shin, Jae-Gook
    Chang, Kiyuk
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (10): : 558 - 562
  • [8] Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant
    Mehta, Meha
    Gajjar, Normi
    Patel, Rutvi
    Joshi, Lipi
    Shah, Gaurang
    INDIAN JOURNAL OF PHARMACOLOGY, 2023, 55 (01) : 27 - 33
  • [9] CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention
    Kassimis, George
    Davlouros, Periklis
    Xanthopoulou, Ioanna
    Stavrou, Eleana F.
    Athanassiadou, Aglaia
    Alexopoulos, Dimitrios
    THROMBOSIS RESEARCH, 2012, 129 (04) : 441 - 446
  • [10] CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis
    Mega, Jessica L.
    Simon, Tabassome
    Anderson, Jeffrey L.
    Bliden, Kevin
    Collet, Jean-Phillippe
    Danchin, Nicolas
    Giusti, Betti
    Gurbel, Paul
    Horne, Benjamin D.
    Kastrati, Adnan
    Montalescot, Gilles
    Neumann, Franz-Josef
    Shen, Lei
    Sibbing, Dirk
    Steg, P. Gabriel
    Trenk, Dietmar
    Wiviott, Stephen D.
    Sabatine, Marc S.
    CIRCULATION, 2009, 120 (18) : S598 - S599
12345